Nabucox (Nabumetone)

Nabumetone, marketed as Nabucox, is an NSAID that reduces inflammation in musculoskeletal disorders.

• Osteoarthritis: alleviates joint pain and stiffness, improving functional mobility.
• Rheumatoid arthritis: decreases synovial inflammation and pain, helping to preserve joint function.
• Ankylosing spondylitis: reduces spinal inflammation and associated discomfort, supporting better posture and movement.
• Acute pain: provides rapid relief of short‑term musculoskeletal pain episodes.

• Nabumetone is a prodrug that is rapidly converted to its active metabolite, which reversibly inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes. By blocking COX activity, the drug lowers prostaglandin synthesis in inflamed tissues, thereby diminishing pain, swelling and fever without directly affecting platelet function. This selective reduction of prostaglandins underlies its anti‑inflammatory and analgesic properties. The inhibition is dose‑dependent and contributes to the clinical efficacy observed in chronic inflammatory conditions.

Nabumetone may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness: transient sensation of light‑headedness.
• Skin rash: mild erythema or itching.

Serious or Rare Side Effects

• Peptic ulcer disease: gastrointestinal bleeding or perforation.
• Hepatotoxicity: elevated liver enzymes or hepatitis.
• Severe hypersensitivity: angioedema, bronchospasm or anaphylaxis.
• Renal impairment: acute kidney injury or worsening chronic kidney disease.

When prescribing Nabucox, clinicians should consider several precautionary measures to minimize risk.

• Assess renal function: evaluate creatinine clearance before initiating therapy.
• Monitor hepatic status: check liver enzymes periodically during treatment.
• Use lowest effective dose: limit exposure to reduce gastrointestinal toxicity.
• Avoid in patients with active ulcer disease: consider alternative therapy.
• Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Nabumetone can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may reduce antihypertensive effect and impair renal function.
• Diuretics: heightened risk of renal impairment.
• Lithium: NSAIDs can increase lithium serum concentrations.